Christopher Shilling

1.2k total citations
12 papers, 550 citations indexed

About

Christopher Shilling is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Christopher Shilling has authored 12 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Genetics. Recurrent topics in Christopher Shilling's work include Muscle Physiology and Disorders (8 papers), Virus-based gene therapy research (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). Christopher Shilling is often cited by papers focused on Muscle Physiology and Disorders (8 papers), Virus-based gene therapy research (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). Christopher Shilling collaborates with scholars based in United States, Italy and Israel. Christopher Shilling's co-authors include Jerry R. Mendell, Christopher M. Walker, Zarife Sahenk, K. Reed Clark, Patricia M. Glibert, Janaiah Kota, Louise R. Rodino‐Klapac, Jessica Alexander, William G. Bremer and Chrystal L. Montgomery and has published in prestigious journals such as Neurology, Annals of Neurology and Science Translational Medicine.

In The Last Decade

Christopher Shilling

12 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Shilling United States 7 370 159 111 103 92 12 550
Patrick Salois Canada 9 295 0.8× 70 0.4× 22 0.2× 41 0.4× 80 0.9× 10 548
Ahmed Aamiri France 11 324 0.9× 52 0.3× 15 0.1× 11 0.1× 27 0.3× 18 466
Davide Randazzo United States 13 254 0.7× 17 0.1× 85 0.8× 26 0.3× 36 0.4× 20 432
Brian J. Henson United States 8 471 1.3× 27 0.2× 44 0.4× 9 0.1× 18 0.2× 10 646
A. Wasik Poland 10 155 0.4× 17 0.1× 14 0.1× 64 0.6× 76 0.8× 29 405
Triantafyllos Tafas Greece 13 107 0.3× 152 1.0× 8 0.1× 35 0.3× 63 0.7× 23 537
Laëtitia Duboscq-Bidot France 10 290 0.8× 18 0.1× 311 2.8× 12 0.1× 78 0.8× 17 550
Fugui Li China 13 193 0.5× 46 0.3× 5 0.0× 39 0.4× 10 0.1× 45 467
Rose Tam Canada 12 333 0.9× 43 0.3× 26 0.2× 10 0.1× 12 0.1× 23 626
Jiexia Quan United States 11 192 0.5× 70 0.4× 24 0.2× 32 0.3× 13 0.1× 22 509

Countries citing papers authored by Christopher Shilling

Since Specialization
Citations

This map shows the geographic impact of Christopher Shilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Shilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Shilling more than expected).

Fields of papers citing papers by Christopher Shilling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Shilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Shilling. The network helps show where Christopher Shilling may publish in the future.

Co-authorship network of co-authors of Christopher Shilling

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Shilling. A scholar is included among the top collaborators of Christopher Shilling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Shilling. Christopher Shilling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Meadows, Aaron S., F. Jason Duncan, Marybeth Camboni, et al.. (2015). A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB. PubMed. 26(4). 228–242. 20 indexed citations
5.
Kaye, Edward M., Jerry R. Mendell, Louise R. Rodino‐Klapac, et al.. (2014). Results at 96 Weeks of a Phase IIb Extension Study of the Exon-Skipping Drug Eteplirsen in Patients with Duchenne Muscular Dystrophy (DMD) (S6.002). Neurology. 82(10_supplement). 1 indexed citations
6.
Mendell, J., Louise R. Rodino‐Klapac, Zarife Sahenk, et al.. (2013). P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD. Neuromuscular Disorders. 23(9-10). 804–805. 1 indexed citations
7.
Mendell, J., Christopher Shilling, N. Leslie, et al.. (2012). D.O.1 A two-tiered approach to newborn screening for Duchenne muscular dystrophy (DMD) using dried blood spots for sequential CK and DNA analysis. Neuromuscular Disorders. 22(9-10). 805–805. 1 indexed citations
8.
Mendell, Jerry R., Louise R. Rodino‐Klapac, Janaiah Kota, et al.. (2009). Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteins. Annals of Neurology. 66(3). 290–297. 163 indexed citations
9.
Glibert, Patricia M., et al.. (2009). Grazing by Karenia brevis on Synechococcus enhances its growth rate and may help to sustain blooms. Aquatic Microbial Ecology. 55. 17–30. 104 indexed citations
10.
Kota, Janaiah, Chalonda R. Handy, Amanda M. Haidet, et al.. (2009). Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates. Science Translational Medicine. 1(6). 6ra15–6ra15. 132 indexed citations
11.
Rosales, Xiomara Q., et al.. (2008). Fidelity of Gamma-Glutamyl Transferase (GGT) in Differentiating Skeletal Muscle From Liver Damage. Journal of Child Neurology. 23(7). 748–751. 21 indexed citations
12.
Eisenberg, Iris, Hagit Hochner, Mira Korner, et al.. (2002). Mutations spectrum ofGNE in hereditary inclusion body myopathy sparing the quadriceps. Human Mutation. 21(1). 99–99. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026